Hsien-Yuan Lane (H-Y Lane)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 39

Top Topics

Machine Learning

Artificial Intelligence

Major Depressive Disorder

Mild Cognitive Impairment

Top Venues

International journal of molecular sciences

Nature medicine

Journal of psychopharmacology (Oxford, England)

International journal of environmental research and public health

This page only lists publications with an associated author ORCID identifier.

Publications

Ching-Lun Tsai, Chi-Ming Chu, Hsien-Yuan Lane, Shiah-Lian Chen, Cheng-Hao Tu, Wei-Fen Ma
The Comparison of Lifestyles, Mental Risks, and Physical Indices among Individuals with Ultra-High Risk of Psychosis, Patients with Schizophrenia, and the General Public. Behavioral sciences (Basel, Switzerland) 14 (5) (2024)
Paul Glue, Colleen Loo, Johnson Fam, Hsien-Yuan Lane, Allan H Young, Peter Surman, null null
Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nature medicine 30 (7) (2024)
Paul Glue, Colleen Loo, Johnson Fam, Hsien-Yuan Lane, Allan H Young, Peter Surman, null null
Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nature medicine 30 (7) (2024)
Ching-Lun Tsai, Chi-Ming Chu, Hsien-Yuan Lane, Shiah-Lian Chen, Cheng-Hao Tu, Wei-Fen Ma
The Comparison of Lifestyles, Mental Risks, and Physical Indices among Individuals with Ultra-High Risk of Psychosis, Patients with Schizophrenia, and the General Public. Behavioral sciences (Basel, Switzerland) 14 (5) (2024)
Paul Glue, Colleen Loo, Johnson Fam, Hsien-Yuan Lane, Allan H Young, Peter Surman, null null
Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nature medicine 30 (7) (2024)
Paul Glue, Colleen Loo, Johnson Fam, Hsien-Yuan Lane, Allan H Young, Peter Surman, null null
Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nature medicine 30 (7) (2024)
Paul Glue, Colleen Loo, Johnson Fam, Hsien-Yuan Lane, Allan H Young, Peter Surman, null null
Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Nature medicine (2024)
Jose De Leon, Georgios Schoretsanitis, Robert Løvsletten Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, Ismael Olmos, Carina Ricciardi, Celso Iglesias-Garcia, Ana Iglesias-Alonso, Edoardo Spina, Can-Jun Ruan, Chuan-Yue Wang, Gang Wang, Yi-Lang Tang, Shih Ku Lin, Hsien-Yuan Lane, Yong Sik Kim, Se Hyun Kim, Anto P Rajkumar, Dinora Fabiola González Esquivel, Helgi Jung-Cook, Trino Baptista, Christopher Rohde, Jimmi Nielsen, Hélène Verdoux, Clelia Quiles, Emílio J Sanz, Carlos de Las Cuevas, Dan Cohen, Peter F J Schulte, Aygün Ertuğrul, Elif Anıl Yağcıoğlu, Nitin Chopra, Betsy McCollum, Charles Shelton, Robert O Cotes, Arun R Kaithi, John M Kane, Saeed Farooq, Chee H Ng, John Bilbily, Christoph Hiemke, Carlos López-Jaramillo, Ian R McGrane, Fernando Lana, Chin Bin Eap, Manuel Arrojo-Romero, Flavian Ş Rădulescu, Erich Seifritz, Susanna Every-Palmer, Chad A Bousman, Emmanuel Bebawi, Rahul Bhattacharya, Deanna L Kelly, Yuji Otsuka, Judit Lazary, Rafael Torres, Agustin Yecora, Mariano Motuca, Kit Wa Sherry Chan, Monica Zolezzi, Sami Ouanes, Domenico de Berardis, Sandeep Grover, Ric M Procyshyn, Richard A Adebayo, Oleg O Kirilochev, Andrey Soloviev, Konstantinos N Fountoulakis, Alina Wilkowska, Wiesław Jerzy Cubała, Muhammad Ayub, Alzira Silva, Raphael M Bonelli, Jose M Villagrán-Moreno, Jacqueline Mayoral-van Son, Henk S Temmingh, Eric H Decloedt, Maria R Pedro, Hiroyoshi Takeuchi, Masaru Tsukahara, Gerhard Gründer, Marina Šagud, Andreja Celofiga, Dragana Ignjatovic Ristic, Bruno B Ortiz, Helio Elkis, Antônio Pacheco Palha, Adrián LLerena, Emilio Fernandez-Egea, Dan J Siskind, Abraham Weizman, Rim Masmoudi, Shamin Mohd Saffian, Jonathan G Leung, Peter F Buckley, Stephen R Marder, Citrome Leslie, Oliver Freudenreich, Christoph U Correll, Daniel J Mueller
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry 55 (2) (2022)
Hsien-Yuan Lane, Shi-Heng Wang, Chieh-Hsin Lin
Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease. Psychiatry and clinical neurosciences (2022)
Yu-Feng Lin, Jia-Jun Liu, Yu-Jen Chang, Chin-Sheng Yu, Wei Yi, Hsien-Yuan Lane, Chih-Hao Lu
Predicting Anticancer Drug Resistance Mediated by Mutations. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Wen-Yu Hsu, Ting-Gang Chang, Cheng-Chen Chang, Nan-Ying Chiu, Chieh-Hsin Lin, Hsien-Yuan Lane
Suicide Ideation among Outpatients with Alcohol Use Disorder. Behavioural neurology 2022 (2022)
Kuan-Cheng Chang, Ke-Wei Chen, Chieh-Liang Huang, Wen-Ling Liao, Mei-Yao Wu, Yu-Kai Lin, Yi-Tzone Shiao, Wei-Hsin Chung, Yen-Nien Lin, Hsien-Yuan Lane
Association of a Common NOS1AP Variant with Attenuation of QTc Prolongation in Men with Heroin Dependence Undergoing Methadone Treatment. Journal of personalized medicine 12 (5) (2022)
Kah Kheng Goh, Chun-Hsin Chen, Hsien-Yuan Lane
Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment. International journal of molecular sciences 22 (4) (2021)
Chieh-Liang Huang, Ping-Ho Chen, Hsien-Yuan Lane, Ing-Kang Ho, Chia-Min Chung
Risk Assessment for Heroin Use and Craving Score Using Polygenic Risk Score. Journal of personalized medicine 11 (4) (2021)
Ching-Lun Tsai, Cheng-Hao Tu, Jui-Cheng Chen, Hsien-Yuan Lane, Wei-Fen Ma
Efficiency of an Online Health-Promotion Program in Individuals with At-Risk Mental State during the COVID-19 Pandemic. International journal of environmental research and public health 18 (22) (2021)
Chun-Hung Chang, Chieh-Hsin Lin, Chieh-Yu Liu, Chih-Sheng Huang, Shaw-Ji Chen, Wen-Cheng Lin, Hui-Ting Yang, Hsien-Yuan Lane
Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches. Journal of psychopharmacology (Oxford, England) 35 (3) (2021)
Chun-Hung Chang, Chieh-Hsin Lin, Hsien-Yuan Lane
Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease. International journal of molecular sciences 22 (5) (2021)
Chieh-Hsin Lin, Hsien-Yuan Lane
Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective Study. Antioxidants (Basel, Switzerland) 10 (11) (2021)
Eugene Lin, Chieh-Hsin Lin, Hsien-Yuan Lane
Deep Learning with Neuroimaging and Genomics in Alzheimer's Disease. International journal of molecular sciences 22 (15) (2021)
Yu-Jung Cheng, Chieh-Hsin Lin, Hsien-Yuan Lane
From Menopause to Neurodegeneration-Molecular Basis and Potential Therapy. International journal of molecular sciences 22 (16) (2021)
Chien-Yi Kuo, Chieh-Hsin Lin, Hsien-Yuan Lane
Molecular Basis of Late-Life Depression. International journal of molecular sciences 22 (14) (2021)
Chieh-Hsin Lin, Hung Su, Chung-Chieh Hung, Hsien-Yuan Lane, Jentaie Shiea
Characterization of Potential Protein Biomarkers for Major Depressive Disorder Using Matrix-Assisted Laser Desorption Ionization/Time-of-Flight Mass Spectrometry. Molecules (Basel, Switzerland) 26 (15) (2021)
Jose De Leon, Georgios Schoretsanitis, Robert Løvsletten Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, Ismael Olmos, Carina Ricciardi, Celso Iglesias-Garcia, Ana Iglesias-Alonso, Edoardo Spina, Can-Jun Ruan, Chuan-Yue Wang, Gang Wang, Yi-Lang Tang, Shih Ku Lin, Hsien-Yuan Lane, Yong Sik Kim, Se Hyun Kim, Anto P Rajkumar, Dinora Fabiola González Esquivel, Helgi Jung-Cook, Trino Baptista, Christopher Rohde, Jimmi Nielsen, Hélène Verdoux, Clelia Quiles, Emílio J Sanz, Carlos de Las Cuevas, Dan Cohen, Peter F J Schulte, Aygün Ertuğrul, Elif Anıl Yağcıoğlu, Nitin Chopra, Betsy McCollum, Charles Shelton, Robert O Cotes, Arun R Kaithi, John M Kane, Saeed Farooq, Chee H Ng, John Bilbily, Christoph Hiemke, Carlos López-Jaramillo, Ian R McGrane, Fernando Lana, Chin Bin Eap, Manuel Arrojo-Romero, Flavian Ş Rădulescu, Erich Seifritz, Susanna Every-Palmer, Chad A Bousman, Emmanuel Bebawi, Rahul Bhattacharya, Deanna L Kelly, Yuji Otsuka, Judit Lazary, Rafael Torres, Agustin Yecora, Mariano Motuca, Kit Wa Sherry Chan, Monica Zolezzi, Sami Ouanes, Domenico de Berardis, Sandeep Grover, Ric M Procyshyn, Richard A Adebayo, Oleg O Kirilochev, Andrey Soloviev, Konstantinos N Fountoulakis, Alina Wilkowska, Wiesław Jerzy Cubała, Muhammad Ayub, Alzira Silva, Raphael M Bonelli, Jose M Villagrán-Moreno, Jacqueline Mayoral-van Son, Henk S Temmingh, Eric H Decloedt, Maria R Pedro, Hiroyoshi Takeuchi, Masaru Tsukahara, Gerhard Gründer, Marina Šagud, Andreja Celofiga, Dragana Ignjatovic Ristic, Bruno B Ortiz, Helio Elkis, Antônio Pacheco Palha, Adrián LLerena, Emilio Fernandez-Egea, Dan J Siskind, Abraham Weizman, Rim Masmoudi, Shamin Mohd Saffian, Jonathan G Leung, Peter F Buckley, Stephen R Marder, Citrome Leslie, Oliver Freudenreich, Christoph U Correll, Daniel J Mueller
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry 55 (2) (2021)
Tien-Wei Yu, Hsien-Yuan Lane, Chieh-Hsin Lin
Novel Therapeutic Approaches for Alzheimer's Disease: An Updated Review. International journal of molecular sciences 22 (15) (2021)
Ching-Lun Tsai, Ya-Wen Lin, Hsing-Chi Hsu, Mei-Ling Lou, Hsien-Yuan Lane, Cheng-Hao Tu, Wei-Fen Ma
Effects of the Health-Awareness-Strengthening Lifestyle Program in a Randomized Trial of Young Adults with an At-Risk Mental State. International journal of environmental research and public health 18 (4) (2021)
Hsien-Yuan Lane, Chin-Jui Chang, Chieh-Liang Huang, Yun-Hsuan Chang
An Investigation into Smartphone Addiction with Personality and Sleep Quality among University Students. International journal of environmental research and public health 18 (14) (2021)
Yu-Jung Cheng, Chieh-Hsin Lin, Hsien-Yuan Lane
d-Amino Acids and pLG72 in Alzheimer's Disease and Schizophrenia. International journal of molecular sciences 22 (20) (2021)
Yu-Jung Cheng, Chieh-Hsin Lin, Hsien-Yuan Lane
Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer's Disease. International journal of molecular sciences 22 (5) (2021)
Chung-Chieh Hung, Chieh-Hsin Lin, Hsien-Yuan Lane
Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment. International journal of molecular sciences 22 (18) (2021)
Jane Pei-Chen Chang, Kuo-Hao Huang, Chieh-Hsin Lin, Hsien-Yuan Lane
Genetic Effects of DISC1 and G72 (DAOA) on Visual Learning of Patients with Schizophrenia. Neuropsychiatric disease and treatment 16 (2020)
Chun-Hung Chang, Chieh-Hsin Lin, Hsien-Yuan Lane
d-glutamate and Gut Microbiota in Alzheimer's Disease. International journal of molecular sciences 21 (8) (2020)
Chieh-Hsin Lin, Hui-Ting Yang, Ping-Kun Chen, Shi-Heng Wang, Hsien-Yuan Lane
Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD). Neuropsychiatric disease and treatment 16 (2020)
Eugene Lin, Chieh-Hsin Lin, Hsien-Yuan Lane
Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design. Molecules (Basel, Switzerland) 25 (14) (2020)
Eugene Lin, Chieh-Hsin Lin, Hsien-Yuan Lane
Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches. International journal of molecular sciences 21 (3) (2020)
Chun-Hung Chang, Chieh-Hsin Lin, Chieh-Yu Liu, Shaw-Ji Chen, Hsien-Yuan Lane
Efficacy and cognitive effect of sarcosine (N-methylglycine) in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials. Journal of psychopharmacology (Oxford, England) 34 (5) (2020)
Chun-Hung Chang, Hsien-Yuan Lane, Ping-Tao Tseng, Shaw-Ji Chen, Chieh-Yu Liu, Chieh-Hsin Lin
Effect of N-methyl-D-aspartate-receptor-enhancing agents on cognition in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials. Journal of psychopharmacology (Oxford, England) 33 (4) (2019)
C-H Lin, P-K Chen, S-H Wang, Hsien-Yuan Lane
Sodium benzoate for the treatment of behavioral and psychological symptoms of dementia (BPSD): A randomized, double-blind, placebo-controlled, 6-week trial. Journal of psychopharmacology (Oxford, England) 33 (8) (2019)
Wei-Ting Tseng, Jia-Yin Yeh, Hsien-Yuan Lane, Chieh-Hsin Lin
Effects of donepezil on cognition and global functioning in patients with delayed encephalopathy after carbon monoxide poisoning: A case series. Psychiatry and clinical neurosciences 73 (6) (2019)
Chun-Hung Chang, Hsien-Yuan Lane, Chieh-Yu Liu, Po-Chih Cheng, Shaw-Ji Chen, Chieh-Hsin Lin
C-reactive protein is associated with severity of thought and language dysfunction in patients with schizophrenia. Neuropsychiatric disease and treatment 15 (2019)